• Home
  • Life Sciences

Training courses & Webinars:
Life Sciences

Our life sciences training courses cover Pharmaceuticals, Medical Devices, IVDs, Biotech/Biopharma and Animal Health and have been designed to focus on regulatory affairs, clinical trials, pharmacovigilance, medical writing, latest developments, and best practices (GxP).  Our portfolio of events is extensive and provides training from basic to advanced levels in a variety of formats.  

The pandemic created numerous challenges across all areas of business worldwide and companies had to respond and adapt very quickly. Now, as the healthcare sector emerges stronger and with renewed strategy, life science companies continue to focus on key areas for development, explore the use of emerging technologies, and seek opportunities to harness collaborations and build resilience. 

 

Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

Biopharma

Next events:

  • 30 Sep-1 Oct 2025 Biosimilars
  • 20-21 Oct 2025 Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

See all 10 courses

Clinical Research

Next events:

  • 15-16 Sep 2025 Clinical Trial Regulatory Requirements
  • 18-19 Sep 2025 Clinical Quality Management Systems

See all 31 courses

GxP

Next events:

  • 30 Sep-2 Oct 2025 An Introduction to Pharmaceutical Packaging
  • 2-3 Oct 2025 Development of Combination Products: Critical Interactions

See all 47 courses

Medical Technology

Next events:

  • 16-17 Sep 2025 Human Factors and Usability Engineering in the Development of Drug Delivery Products
  • 8-9 Oct 2025 Metered Dose Inhaler (MDI) Technology

See all 20 courses

Medical Writing

Next events:

  • 30 Sep 2025 Effective Technical Writing & Editing
  • 20-21 Nov 2025 Medical Writing for Medical Devices

See all 8 courses

Regulatory Affairs

Next events:

  • 16 Sep 2025 EU Proposed Pharmaceutical Legislation Changes
  • 16-17 Sep 2025 Human Factors and Usability Engineering in the Development of Drug Delivery Products

See all 106 courses

Vigilance

Next events:

  • 25-26 Sep 2025 Pharmacovigilance QMS & Inspection Preparation
  • 3 Oct 2025 A Practical Guide to Producing and Maintaining the PSMF

See all 33 courses

In-house training

We can provide any of our courses on an in-house basis - at your location or online, with a programme and presenters tailored to your exact requirements. If you require training for multiple staff members, contact us to see how we can work with you.

Previous attendees said...

“Very good. I was expected to improve my knowledge and get some tips and I did it.”

Manon Schönholzer, Drug Safety officer, CIS Bio international

“It was a very very informative webinar which I certainly will recommend to others”

Nanna Sommer, Clinical Trial Assistant, Minervax ApS

“Overall very good.”

William Hensler, Principal, Alantra BioPharma

“The overall content was strong and informative and I believe there was a good mix of discussions, workshops and information. I wanted to deepen my understanding of clinical trial monitoring, particularly the common pitfalls and how to manage them effectively and how to best monitor online/off-site. I believe I’ve learned several valuable methods for identifying and evaluating issues when something goes wrong in a clinical study. I found the sections on risk-based monitoring approaches very insightful and applicable to my work. I also gained insights into ensuring patient safety and maintaining data integrity, as well as the principles of risk-based monitoring. The session on root cause analysis was especially valuable, and I plan to implement this approach in my own clinical study. Overall, I feel that I’ve achieved the goals I set out for this course.”

Isabella Åström, Clinical Research Associate, Atos Medical

“The programme was well-structured and informative. The session provided practical guidance on structuring SOPs, using clear and concise language, and tailoring content to the intended audience. The real-world examples and actionable tips were especially valuable, and I now feel more confident in my ability to revise or create SOPs that align with current standards and expectations. The speaker was very knowledgeable and engaging throughout. Her expertise in SOP writing was clear, and she communicated complex ideas in a straightforward and easy-to-understand way. I particularly appreciated the practical examples and real-life scenarios shared, which made the content more relatable and actionable. She also encouraged questions and interaction, creating a welcoming and supportive learning atmosphere. Overall, her delivery significantly enhanced the quality and value of the training. It struck a good balance between theory and actionable advice, which made it easy to understand and apply.

In summary, the webinar was a valuable learning experience that provided useful tools and insights for writing effective SOPs.”

Amalia Neophytou, Trainer Analyst, Remedica Ltd

“Group tasks were good, as the interactive parts put theory into practice. Language, speed, flow, and overall presentation was good and easy to follow. Absolutely worth while as an intro to writing of SOPs.”

Thomas Bidstrup, Clinical Research Specialist, Ambu A/S

“I hoped to achieve a full picture of APIs for my new job and yes I accomplished it. A lot of information..
”

Marie Lucchini, Regulatory affairs Supervisor, Actylis

“I have accomplished a better understanding of API's after the two day webinar. Very good webinar which covers a good range of content, a little dense, so will need to refer back to it at some stage. Speakers were nice and accommodating. They clearly have a good understanding of the content they are presenting.”

Stephany Banglayan, Research and Development Analyst, Xeolas Pharmaceuticals

“I hoped to achieve a full picture of APIs for my new job and yes I accomplished it. A lot of information..
”

Marie Lucchini, Regulatory affairs Supervisor, Actylis

“I have accomplished a better understanding of API's after the two day webinar. Very good webinar which covers a good range of content, a little dense, so will need to refer back to it at some stage. Speakers were nice and accommodating. They clearly have a good understanding of the content they are presenting.”

Stephany Banglayan, Research and Development Analyst, Xeolas Pharmaceuticals